Cite
HARVARD Citation
Helzberg, J. et al. (n.d.). S442 Utilization of Diagnostic Testing and Indications for Long-Term Twice-Daily Proton Pump Inhibitor (PPI) Therapy for Gastroesophageal Reflux Disease (GERD) in a Large Healthcare System. American journal of gastroenterology. pp. e312-e313. [Online].